Search precisely by journal name, ISSN, publisher, or subject category
BMC Clinical Pathology is an open access journal publishing original peer-reviewed research articles in all aspects of histopathology, haematology, clinical biochemistry, and medical microbiology (including virology, parasitology, and infection control). BMC Clinical Pathology (ISSN 1472-6890) is indexed/tracked/covered by PubMed, CAS, EMBASE, Scopus and Google Scholar.
Comparative Clinical Pathology provides a source for the publication of reviews, research reports, technical notes and case histories covering all aspects of haematology and clinical chemistry in mammalian species. Comparative aspects of our work refers to differences in amount, number, degree, or quality from normal or expected findings, and often is related to comparison between differing species including human.The journal addresses itself to all scientists with an interest in the field of comparative clinical pathology such as, but not limited to, research institutes, toxicology and pathology laboratories, medical and veterinary universities, colleges and practices, teaching hospitals and zoological institutes. To be considered for publication in Comparative Clinical Pathology papers should address aspects of comparative clinical pathology and may include; · classical haematology and clinical chemistry, · toxicology, · endocrinology· immunology, immunodeficiency states, immunotoxicology· haemostasis, · haematopoietic and other malignancies, · immunophenotyping, cellular lineage, · functional identification and biomarkers. Articles may incorporate: normal and abnormal values, normal and abnormal reactions, human, veterinary and zoological data, diagnostic and toxicological changes, impact on diagnosis and disease control, experimental studies and new technologies. Experimental studies can incorporate data from both in vivo and in vitro studies, but should not be wholly in vitro. Articles may also include appropriate data and information from other disciplines such as histopathology, and include such other specialist techniques as immunohistochemistry where relevant to comparative clinical pathology.
This journal aims to offer expert review articles on the most important recent research pertaining to biological mechanisms underlying disease, including etiology, pathogenesis, and the clinical manifestations of cellular alteration. By providing clear, insightful, balanced contributions, the journal intends to serve those for whom the elucidation of new techniques and technologies related to pathobiology is essential. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas across the field. Section Editors select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An Editorial Board of more than 20 internationally diverse members reviews the annual table of contents, ensures that topics include emerging research, and suggests topics of special importance to their country/region. Topics covered may include autophagy, cancer stem cells, induced pluripotential stem cells (iPS cells), inflammation and cancer, matrix pathobiology, miRNA in pathobiology, mitochondrial dysfunction/diseases, and myofibroblast.